product
DiscoverX BioMAP® Tox alert™ analysis
28 July 2016 | By DiscoverX Corporation
In vitro detection of potential in vivo toxicity and adverse events...
List view / Grid view
Biomarkers
Biomarkers are a naturally occurring molecule, gene, or characteristic by which a particular disease can be identified.
news
Probiodrug and Crossbeta team up for Alzheimer’s disease biomarkers
30 June 2016 | By Victoria White, Digital Content Producer
The partnership will allow Probiodrug to utilise Crossbeta’s proprietary technology in support of Probiodrug’s biomarker development activities...
news
Biomarkers that could give better cancer survival estimates
9 June 2016 | By Victoria White, Digital Content Producer
A new method, developed by UCLA scientists, could eventually lead to a way to improve accuracy of how well a patient will respond to treatment...
whitepaper
Analyte Quarterly #1: Bring your biomarkers to life
Volume 1 2016 of EMD Millipore's "Analyte Quarterly" provides details of all their Immunoassays & MILLIPLEX® map Kits...
news
New biomarkers for TB could lead to improved vaccines
12 April 2016 | By Victoria White, Digital Content Producer
A team of scientists have identified new biomarkers for TB which have shown for the first time why immunity from the widely used BCG vaccine is so variable...
news
Genetic link confirmed between DCIS and development of invasive breast cancer
12 April 2016 | By Victoria White, Digital Content Producer
The discovery means that a family history of DCIS could be as important to assessing a woman’s risk as a history of invasive breast cancer...
news
Epiregulin identified as a possible target in lung cancer
8 April 2016 | By Victoria White, Digital Content Producer
A study found that in addition to decreased overall tumour burden, mice lacking epiregulin also showed reduced inflammation...
article
Strategies for identifying predictive biomarkers of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD), a consequence of sedentary life styles and high fat diets, has an estimated prevalence of about 30% in western countries. It is associated with insulin resistance, obesity, glucose intolerance and drug toxicity. Additionally, polymorphisms within genes such as PNPLA3, TM6SF2, APOC3, NCAN and PPP1R3B correlate…
news
SRI International awarded $19.8m to develop cancer preventive vaccines
15 March 2016 | By Victoria White
A division of SRI International will conduct preclinical studies to assess the efficacy of compounds or vaccines for preventing invasive-cancer development...
news
Pfizer to give a keynote address on reviving covalent drug design in oncology at SMi’s 15th annual event this February
29 January 2016 | By SMi Group
SMi group reports: Doug Johnson, Research Fellow at Pfizer will be giving a keynote address on Day 1 at the SMi’s 15th annual Advances and Progress in Drug Design conference...
news
Karolinska Institutet and Biovica to evaluate promising cancer treatments
29 January 2016 | By Victoria White
The lab headed by Thomas Helleday at Karolinska Institutet and Biovica are to collaborate to improve evaluation of new, promising cancer therapies...
news
New biomarkers may influence cancer drug design
22 January 2016 | By Victoria White
The research from Georgia State University scientists provides strong translational potential with respect to biomarkers that play critical roles in the development of endometrial/lung tumours...
news
AstraZeneca and MedImmune to harness the power of the Secretome
11 December 2015 | By Victoria White
The companies have joined WCPR to develop new technologies for biologics production and to identify new targets for disease research in the ground-breaking area of the Secretome...
article
Drug Target Review – Issue #4 2015
3 December 2015 | By Drug Target Review
Included in this issue: Biomarkers, Mass Spectrometry, Target Validation, Drug Development, Personalised Medicines, Next-Generation Sequencing, Protein Expression, Companion Diagnostics, and much more...
article
Biomarkers as molecular footprints for cancer therapy: current perspectives and promises
Knowledge about cancer biomarkers has increased tremendously and provides clinicians and researchers with valued opportunities to understand the molecular mechanism of cancer, thus applying it to effective, early-stage diagnosis and treatment. Cancer biomarkers include a vast range of biochemical molecules such as nucleic acids, proteins, sugars, lipids, small metabolites, cytogenetic…
